Regenerative Biologics Supplier for Orthopedic Practices in Seattle, WA

Vendor qualification for orthopedic groups

Orthopedic practices and ambulatory surgery centers in the Seattle area typically evaluate a biologics supplier before any purchase order is issued. A purchasing or compliance lead usually requests a sample certificate of analysis, a donor eligibility summary and a description of how the product is processed before committing to a vendor.

Multi-surgeon groups and surgery centers in this region often standardize on one supplier across locations so that lot documentation and reorder records stay consistent for every provider using the product.

NPI-verified ordering accounts

Precision Biologics opens accounts only after a practice or individual physician submits an NPI number for verification against the NPPES registry. This applies to every account, regardless of practice size or location.

Front-office staff can submit the NPI and license information for review; our team confirms the account before the first order ships.

Receiving cold-chain shipments in the Pacific Northwest

Cryopreserved Wharton's jelly and exosome products ship overnight on dry ice in validated containers and arrive ready for -80 degree C storage. Clinics receiving a shipment should have a designated staff member confirm the lot number on the shipping label against the packing slip at intake.

Lyophilized formats do not require cryogenic storage on arrival; they are handled and stored according to the product insert included with each lot.

Documentation review and account support

Each lot carries its own identifier and is held in quarantine until third-party sterility testing and internal release criteria are met. Documentation including the certificate of analysis, donor eligibility summary and lot release record is available to verified accounts on request.

Washington-licensed practices should verify with their own medical director, the Washington medical board and legal counsel how a specific intended use is classified under 21 CFR 1271.10; Precision Biologics does not provide clinical or regulatory advice. Our team can schedule a peer-to-peer call between a buyer's physician and ours to walk through documentation, separate from any clinical decision.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.